Showing results (301-310 of 572) with videos related to
Sort By:
Pageof 58
Journal of Leukocyte Biology|May 19, 2020
Frontline Science: Activation of metabolic nuclear receptors restores periodontal tissue homeostasis in mice with leukocyte adhesion deficiency-1Tetsuhiro Kajikawa, Baomei Wang, Xiaofei Li, et al.Annals of the Rheumatic Diseases|November 1, 1990
Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glandsH M Moutsopoulos, A G Tzioufas, M K Bai, et al.Clinical and Experimental Immunology|July 1, 1991
Quantification of cross-reactive idiotype-positive rheumatoid factor produced in autoimmune rheumatic diseases. An indicator of clonality and B cell proliferative mechanismsF Shokri, R A Mageed, G D Kitas, et al.European Journal of Clinical Investigation|July 1, 1992
Patients with anticardiolipin antibodies with and without antiphospholipid syndrome: their clinical features and beta 2-glycoprotein-I plasma levelsP G Vlachoyiannopoulos, S A Krilis, J E Hunt, et al.Rheumatology International|January 1, 1986
Rheumatoid factors in Ro (SSA) positive and Ro (SSA) negative rheumatoid arthritis patientsA E Gharavi, F N Skopouli, B M Patel, et al.Clinical Immunology and Immunopathology|September 1, 1987
Anticardiolipin antibodies in unselected autoimmune rheumatic disease patientsM N Manoussakis, A E Gharavi, A A Drosos, et al.Rheumatology International|January 1, 1987
Esophageal manometric findings in autoimmune rheumatic diseases: is scleroderma esophagus a specific entity?E B Tsianos, A A Drosos, C D Chiras, et al.The Journal of Experimental Medicine|July 1, 1979
CBA/N X-linked B-cell defect prevents NZB B-cell hyperactivity in F1 miceJ D Taurog, H M Moutsopoulos, Y J Rosenberg, et al.Annals of the Rheumatic Diseases|September 1, 1986
Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind studyA A Drosos, F N Skopouli, J S Costopoulos, et al.Annals of the Rheumatic Diseases|October 1, 1996
Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosisP G Vlachoyiannopoulos, N Tsifetaki, I Dimitriou, et al.Pageof 58